AKT1-mediated phosphorylation of EZH2 allows its interaction with androgen receptor promoting the expression of androgen receptor-target genes in the absence of androgens further supporting the involvement of EZH2 in the development and progression of castrate resistant prostate cancer [64]. This evidence concerns the gene AR and prostate carcinoma.